Literature DB >> 32964217

Unraveling the Mysteries of Acute Flaccid Myelitis: Scientific Opportunities and Priorities for Future Research.

Andrea M Lerner1, Amanda J DeRocco1, Linda Yang1, Daphne A Robinson1, Robert W Eisinger1, Nicholas D Bushar1, Avindra Nath2, Emily Erbelding3.   

Abstract

Since 2014, cases of acute flaccid myelitis (AFM) have been reported in the United States in increasing numbers biennially, occurring in the late summer and early fall. Although there is unlikely to be a single causative agent of this syndrome, non-polio enteroviruses, including enterovirus D-68 (EV-D68), have had epidemiological and laboratory associations with AFM. Much remains to be known about AFM and AFM-associated enteroviruses, including disease pathogenesis and the best strategies for development of therapeutics or preventive modalities including vaccines. To catalyze research that addresses these scientific and clinical gaps, the National Institute of Allergy and Infectious Diseases convened a workshop entitled "AFM Preparedness: Addressing EV-D68 and Other AFM-Associated Enteroviruses" on 19-20 February 2020. Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Entities:  

Keywords:  acute flaccid myelitis; enterovirus D-68; enteroviruses

Year:  2021        PMID: 32964217     DOI: 10.1093/cid/ciaa1432

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Neutralizing Antibody Given after Paralysis Onset Reduces the Severity of Paralysis Compared to Nonspecific Antibody-Treated Controls in a Mouse Model of EV-D68-Associated Acute Flaccid Myelitis.

Authors:  Michael J Rudy; Joshua Frost; Penny Clarke; Kenneth L Tyler
Journal:  Antimicrob Agents Chemother       Date:  2022-07-27       Impact factor: 5.938

Review 2.  Neurologic complications of coronavirus and other respiratory viral infections.

Authors:  Francesco Cavallieri; Johann Sellner; Marialuisa Zedde; Elena Moro
Journal:  Handb Clin Neurol       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.